Microwave ablation with immunotherapy for advanced lung or liver cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests combining microwave ablation (a procedure that uses heat to destroy tumors) with immunotherapy (drugs that help your immune system fight cancer), with or without drugs that stop blood vessel growth. The goal is to see if this combination is safe and effective for people with advanced lung or liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced non-small cell lung cancer or liver cancer that has already been treated with systemic therapy.
- Your doctor expects you to live at least 3 more months.
- You are between 18 and 75 years old.
- You are feeling reasonably well (able to do light activity).
- Your blood counts and liver/kidney function are within acceptable limits.
- If you are of childbearing age, you must agree to use effective birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining microwave ablation (heat treatment of tumors) with two drugs—tislelizumab (an immune-boosting drug) and docetaxel (chemotherapy)—for patients with advanced non-small cell lung cancer whose disease progressed after initial immunotherapy. The goal is to see if this combination can slow or shrink tumors better than standard treatment alone.
This Phase 2 trial studies whether combining microwave ablation (a procedure to destroy lung tumors) with an immune checkpoint inhibitor can control multiple early lung cancers safely. It also aims to see how well the immune treatment helps after ablation, in people whose cancers have not spread.
This study combines microwave ablation, which uses heat to destroy cancer cells, with immune cell therapy that boosts your body's natural defenses to fight the cancer. It may help people with early-stage liver cancer who cannot have surgery.
This trial tests a minimally invasive procedure that uses microwave energy to destroy lung tumors. It is for people who are already candidates for surgery but may want a less invasive option.
This trial tests whether combining pembrolizumab (an immune treatment) with a lung ablation procedure can be safer and more effective for advanced non-small cell lung cancer after standard first treatment fails or the cancer comes back. It may help shrink tumors and improve control of the disease.
This study tests a new, less invasive way to treat lung cancer using microwave energy delivered through a thin tube inserted into the airway. It is for people with small, confirmed lung tumors who are already being considered for surgery, and who cannot or prefer not to have blood thinners.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.